Vitrolife AB (FRA:VTFN) 3-Year Revenue Growth Rate : 31.20% (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB 3-Year Revenue Growth Rate?

Vitrolife AB's Revenue per Share for the three months ended in Mar. 2024 was €0.55.

During the past 12 months, Vitrolife AB's average Revenue per Share Growth Rate was 4.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 31.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 20.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 18.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Vitrolife AB was 31.20% per year. The lowest was 5.20% per year. And the median was 17.50% per year.

Competitive Comparison of Vitrolife AB's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, Vitrolife AB's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vitrolife AB's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's 3-Year Revenue Growth Rate falls into.

Vitrolife AB 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Vitrolife AB (FRA:VTFN) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Vitrolife AB 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Vitrolife AB (FRA:VTFN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (FRA:VTFN) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

VITR:Sweden 0YAY:UK

Address

Box 9080, Gothenburg, SWE, 400 92

Website

https://www.vitrolife.com

Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive advanced support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction.

Vitrolife AB (FRA:VTFN) Headlines

No Headlines